Women's Health ‹ Breast CancerCancer
Breast Cancer Links
- Improving Access to Mammography
- USPSTF Screeniing Guidelines
- Free Mammograms
- 2004-2005 Early Detection Program
- Breast Cancer
- Mammography Screening
- Genetic Testing for Breast and Ovarian Cancer Susceptibility
- Diethylstilbestrol (DES): A breast cancer risk too
- Patterns of Mammography Use in AI in NM
- Breast Cancer after Prophylactic Bilateral Mastectomy
- Tamoxifen and Breast Cancer Incidence
- Breast cancer treatment in older women
- Breast Cancer and Environmental Risk Factors
- Breast cancer risk
- Breast Cancer Risk Assessment Tool, NCI
- Women NOT less likely to die of breast cancer or live longer with mammography:
- Mammography Screening for breast cancer
- Outpatient mastectomies
- U.S. Preventive Services Task Force Tamoxifen Recommendations
- USPSTF recommends drugs to reduce risk of breast cancer
- Donate a free mammogram a day to an underprivileged woman
Breast Cancer Screening
(See below for breast cancer risk assessment/genetics and breast cancer treatment)
Tips for Improving Access to Mammography
USPSTF Breast Cancer Screeniing Guidelines
Breast Cancer Information
Mammogram Rates Among Women 40+ Years Old
2004-2005 Breast and Cervical Cancer Early Detection Program
- The new 2004-2005 Fact Sheet.
Clinical Breast Exam
Mammography Screening Among Low-Income Women
- From CDC Breast and Cervical Cancer Early Detection Program - Health Care Programs need to communicate more effectively with women to encourage routine screening.
Patterns of Mammography Use in American Indians in New Mexico
- This population-based article details a low usage of mammography. Current utilization is unlikely to achieve a potential 30% reduction in breast cancer mortality
Women NOT less likely to die of breast cancer or live longer with mammography:
- Cochrane library recommends reconsidering use of mammography document (Posted February 2002)
Mammography Screening for breast cancer: USPSTF
- U.S. Preventive Services Task Force recommendations for mammography
Breast Cancer Risk Assessment and Genetics
Genetic Testing for Breast and Ovarian Cancer Susceptibility
- Choice for or against genetic testing may not be an easy one
Diethylstilbestrol (DES): A breast cancer risk too
- Intro: DES in pregnancy increases risk for breast cancer (as well as cervical CA)
Breast Cancer after Prophylactic Bilateral Mastectomy in Women with a BRCA1 or BRCA2 Mutation
- In women with a BRCA1 or BRCA2 mutation, prophylactic bilateral total mastectomy reduces the incidence of breast cancer at three years of follow-up. NEJM 2001; 345(3):207-208 Abstract or Editorial
Tamoxifen and Breast Cancer Incidence Among Women with Inherited Mutations in BRCA1 and BRCA2
- As many as 192,200 new cases of invasive breast cancer will be diagnosed among women in the United States in 2001, making it the most common form of cancer in women this year. Three to five of these breast cancer cases will be associated with mutations within the BRCA1 or BRCA2 genes.
Breast Cancer and Environmental Risk Factors (B.C.E.R.F.) program in New York State
- B.C.E.R.F. strives to provide information on environmental risk factors and the risk of breast cancer and other hormonal-dependent cancers.
-
Gail model of breast cancer risk assessment
Breast Cancer Risk Assessment Tool, NCI
- Enables a health care provider to print a woman's risk calculation directly from the Internet
USPSTF recommends drugs to reduce the risk of breast cancer for high risk patients
- The Task Force's recommendations are published in the July 2 issue of Annals of Internal Medicine
Breast Cancer Treatment
Breast cancer treatment in older women often depends on age and treatment preferences
- Nearly half of new breast cancer cases and nearly two-thirds of deaths from this disease occur among women 65 years of age or older. Research summary on-line.
Outpatient mastectomies have increased over the last decade
- This study shows dramatic increases in outpatient complete mastectomies in five States
U.S. Preventive Services Task Force Tamoxifen Recommendations
- Task Forces recommends that clinicians discuss the potential benefits and risks of taking prescription medicines such as tamoxifen to reduce the risk of breast cancer with their female patients who are at high risk for the disease. See the July 2 issue of Annals of Internal Medicine